Effect of Colonoscopy AI System for Colon Polyp Detection According to the Workload of Endoscopy Units

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05089071
Collaborator
Seoul National University (Other)
3,000
1
2
14
214.3

Study Details

Study Description

Brief Summary

Computer-aided detection (CADe) systems have been actively researched for polyp detection in colonoscopy. The investigators aim to identify the effect of CADe system according to the workload of endoscopy units

Condition or Disease Intervention/Treatment Phase
  • Device: Assist by artificial intelligence system for colon polyp detection
N/A

Detailed Description

Artificial intelligence technology based on deep learning is being applied in various medical fields, and research is being actively conducted to develop computer-aided detection (CADe) systems for colonoscopies to overcome the limitation of the variance of human skills. These well-trained CADe systems demonstrated high performance for neoplastic polyp detection and reported a 44% increase in adenoma detection rate (ADR) for endoscopists.

Operator fatigue may negatively influence ADR during a screening colonoscopy, and many studies reported a decrease in ADR according to the increase of working hours and procedure number. Accordingly, the investigators sought to identify the effect of the colonoscopy CADe system according to working hours and procedure numbers in endoscopists with various levels. The investigators hypothesized that the CADe system would be useful to prevent the decrease in ADR in case of a high endoscopy workload.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3000 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Effect of Colonoscopy AI System for Colon Polyp Detection According to the Workload of Endoscopy Units: A Single-center Prospective Study
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: CADe group

Endoscopists perform colonoscopy with CADe system

Device: Assist by artificial intelligence system for colon polyp detection
Assist by artificial intelligence system for colon polyp detection

No Intervention: Control

Endoscopists perform colonoscopy without CADe system

Outcome Measures

Primary Outcome Measures

  1. Adenoma detection rate [8 months]

    proportion of colonoscopies with at least one adenoma detected overall and as detected by the physician.

  2. Sessile serrated lesion detection rate [8 months]

    proportion of colonoscopies with at least one sessile serrated lesion detected overall and as detected by the physician.

Secondary Outcome Measures

  1. polyp detection rate [8 months]

    proportion of colonoscopies with at least one polyp detected overall and as detected by the physician.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

patient for screening or surveillance colonoscopy patients agreed with participating in the study

Exclusion Criteria:

patients who do not agree with participating in the study patients with a history of colon resection patients with a history of inflammatory bowel resection patients with poor bowel preparation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Healthcare System Gangnam Center, Seoul National University Hospital Seoul Korea, Republic of

Sponsors and Collaborators

  • Seoul National University Hospital
  • Seoul National University

Investigators

  • Principal Investigator: Jung Ho Bae, MD, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05089071
Other Study ID Numbers:
  • SNUH IRB 2107-235-1240
First Posted:
Oct 22, 2021
Last Update Posted:
Mar 2, 2022
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2022